Polku Therapeutics
5 employees on LinkedIn · 1 known investors
Polku Therapeutics is a preclinical CNS drug discovery company developing small-molecule therapies that modulate the PREP–PP2A axis to target tau aggregation and neuroinflammation in neurodegenerative diseases. Its lead program pursues disease-modifying treatments for tauopathies and related conditions such as Parkinson's disease, starting with orphan tauopathy indications.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Polku Therapeutics do?
- Polku Therapeutics is a preclinical CNS drug discovery company developing small-molecule therapies that modulate the PREP–PP2A axis to target tau aggregation and neuroinflammation in neurodegenerative diseases. Its lead program pursues disease-modifying treatments for tauopathies and related conditions such as Parkinson's disease, starting with orphan tauopathy indications.
- Who founded Polku Therapeutics?
- Polku Therapeutics was founded by Timo, Erik.
- Who are Polku Therapeutics's investors?
- Polku Therapeutics's investors include Torrey Pines Investment.